• Slide

    HIV/AIDS Europe Roundtable 2017

    20th February 2017, Brussels

  • Slide

    HIV/AIDS Europe Roundtable 2017

    20th February 2017, Brussels

  • Slide

    HIV/AIDS Europe Roundtable 2017

    20th February 2017, Brussels

  • Slide

    HIV/AIDS Europe Roundtable 2017

    20th February 2017, Brussels

  • Slide

    HIV/AIDS Europe Roundtable 2017

    20th February 2017, Brussels

  • Slide

    HIV/AIDS Europe Roundtable 2017

    20th February 2017, Brussels

  • Slide

    HIV/AIDS Europe Roundtable 2017

    20th February 2017, Brussels

  • Slide

    HIV/AIDS Europe Roundtable 2017

    20th February 2017, Brussels

  • Slide

    HIV/AIDS Europe Roundtable 2017

    20th February 2017, Brussels

The human immunodeficiency virus (HIV) is one of the most prevalent communicable diseases in Europe with more than two million people now living with the disease in the region.

HIV infection remains of major public health significance in the European Union and neighbouring countries. In contrast with global decline in new infections, the number of newly reported HIV cases in Europe is increasing.

In 2012, more than 131,000 new HIV infections were reported in Europe and Central Asia, with 29,000 of these cases in the EU and European Economic Area.

Whilst effectual treatments for HIV are available, no cure nor preventative vaccine exist. EU policy has subsequently prioritised both the provision of support for people living with HIV/AIDS and embedding effective behavioural and attitudinal means of prevention. 

This roundtable meeting will bring together; EU policy makers, medical and clinical professionals, academic experts, healthcare players and patient groups, to examine current policy guidelines and strategies on combating HIV/AIDS in the EU.

Participants will benefit from the insights of EU health officials and academic experts and help support the development of recommendations to address issues currrently experienced by patients and clinical researchers. 


Subjects to be addressed include:
  • Latest data surveillance and guidelines
  • Current policy guidelines and strategies on combating HIV/AIDS in the EU
  • Interventions to prevent HIV in priority groups (MSM, Migrants and mobile populations & Injecting Drug Users)
  • HIV testing: Improving access, increasing uptake and effectiveness in the European Union
  • The cost of treatment
  • The commissioning and provision of Pre Exposure Prophylaxis (PrEP)
  • The psychological consequences of HIV infected individuals, their partners and families
  • Providing adequate patient support
  • Antiviral drug resistance
  • Molecular HIV screening
  • Research breakthroughs: HIV Vaccine and therapeutic clinical trials
Networking:

The Roundtable will also provide hours of networking time, including coffee breaks, lunch to ensure participants have the maximum possible time to establish and strengthen relationships, whilst exchanging ideas.